Announcing Clinical Therapeutics Journal Club
An Innovative Online Forum
Bridgewater, NJ, October 5, 2006 - Excerpta Medica announces the launch of Clinical Therapeutics Journal Club - an innovative online resource offering the latest in pharmaceutical progress. Medical professionals can now keep pace with important clinical developments through the original research reports and expert reviews provided at CTJournalClub.com.
Articles accepted for publication in Excerpta Medica’s well-respected print journal Clinical Therapeutics will be considered for one of the featured spots on the CTJournalClub.com Web site. Each article will be accompanied by a short, insightful commentary provided by Clinical Therapeutics Editor-in-Chief, Philip D. Walson, MD, or another member of the Clinical Therapeutics distinguished Editorial Board.
CTJournalClub.com not only offers medical practitioners a convenient way of remaining current, it also offers clinical investigators and research sponsors the chance to extend the presence of their Clinical Therapeutics article. According to Vicki Donoso, Executive Publisher–Clinical Therapeutics, “CTJournalClub.com will provide clinical investigators a wonderful opportunity to further highlight and expand the reach of their clinical work in a scientifically credible forum.”About Excerpta Medica
Excerpta Medica, an Elsevier business, is a global communications company that services global health care clients in the areas of medical education, medical communications, and publication planning. Excerpta Medica brings an experienced team of professionals from pharmaceuticals, health care, and medical publishing to deliver scientific and creative solutions. Excerpta Medica has offices in the US (Bridgewater, NJ) and The Netherlands (Amsterdam).
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
+1 908 547-2070